IMVT
Immunovant Inc

2,216
Mkt Cap
$5.51B
Volume
497,897.00
52W High
$29.25
52W Low
$12.72
PE Ratio
-10.10
IMVT Fundamentals
Price
$26.44
Prev Close
$27.08
Open
$26.70
50D MA
$26.36
Beta
1.03
Avg. Volume
1.38M
EPS (Annual)
-$2.73
P/B
5.58
Rev/Employee
$0.00
$1,876.52
Loading...
Loading...
News
all
press releases
TD Asset Management Inc Sells 56,752 Shares of Immunovant, Inc. $IMVT
TD Asset Management Inc decreased its holdings in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 29.5% during the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
Vanguard Group Inc. Has $110.05 Million Holdings in Immunovant, Inc. $IMVT
Vanguard Group Inc. decreased its position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 2.8% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 6,826,810...
MarketBeat·6h ago
News Placeholder
Citigroup Inc. Sells 75,860 Shares of Immunovant, Inc. $IMVT
Citigroup Inc. cut its position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 23.9% in the third quarter, according to the company in its most recent filing with the Securities and...
MarketBeat·10h ago
News Placeholder
Immunovant (NASDAQ:IMVT) Sets New 52-Week High - Here's What Happened
Immunovant (NASDAQ:IMVT) Reaches New 1-Year High - Still a Buy...
MarketBeat·8d ago
News Placeholder
Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
INDV gears up to report Q4 results as Sublocade growth, Suboxone pressure and 2026 revenue outlook take center stage for investors.
Zacks·14d ago
News Placeholder
Aberdeen Group plc Has $15.83 Million Stock Position in Immunovant, Inc. $IMVT
Aberdeen Group plc boosted its holdings in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 16.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·14d ago
News Placeholder
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Immunovant, Inc. (NASDAQ: IMVT)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Immunovant, Inc. (NASDAQ: IMVT) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...
PR Newswire·16d ago
News Placeholder
Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?
ARQT heads into Q4 earnings with Zoryve sales momentum, while investors eye pipeline updates on Feb. 25.
Zacks·16d ago
News Placeholder
Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
RXRX gears up for Q4 with $25.5 million revenue view as investors eye pipeline updates and REC-4881 progress ahead of FDA talks.
Zacks·16d ago
News Placeholder
Immunovant, Inc. (NASDAQ:IMVT) Receives Average Recommendation of "Moderate Buy" from Analysts
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eleven research firms that are presently covering the company, MarketBeat Ratings...
MarketBeat·16d ago
<
1
2
...
>

Latest IMVT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.